138 related articles for article (PubMed ID: 8759764)
1. Role of vitamin D3-binding protein in activation of mouse macrophages.
Yamamoto N; Naraparaju VR
J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
Yamamoto N; Naraparaju VR
Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
[TBL] [Abstract][Full Text] [Related]
3. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
Yamamoto N; Kumashiro R
J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
[TBL] [Abstract][Full Text] [Related]
4. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
Yamamoto N; Homma S; Millman I
J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
[TBL] [Abstract][Full Text] [Related]
5. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.
Yamamoto N; Homma S; Haddad JG; Kowalski MA
Immunology; 1991 Nov; 74(3):420-4. PubMed ID: 1769691
[TBL] [Abstract][Full Text] [Related]
7. Effect of the Gc-derived macrophage-activating factor precursor (preGcMAF) on phagocytic activation of mouse peritoneal macrophages.
Uto Y; Yamamoto S; Takeuchi R; Nakagawa Y; Hirota K; Terada H; Onizuka S; Nakata E; Hori H
Anticancer Res; 2011 Jul; 31(7):2489-92. PubMed ID: 21873164
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
Yamamoto N; Homma S
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
[TBL] [Abstract][Full Text] [Related]
9. Preparation of Gc protein-derived macrophage activating factor (GcMAF) and its structural characterization and biological activities.
Mohamad SB; Nagasawa H; Uto Y; Hori H
Anticancer Res; 2002; 22(6C):4297-300. PubMed ID: 12553073
[TBL] [Abstract][Full Text] [Related]
10. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
Yamamoto N; Naraparaju VR; Asbell SO
Cancer Res; 1996 Jun; 56(12):2827-31. PubMed ID: 8665521
[TBL] [Abstract][Full Text] [Related]
11. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.
Naraparaju VR; Yamamoto N
Immunol Lett; 1994 Dec; 43(3):143-8. PubMed ID: 7721326
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
13. Contribution of N-acetyl-beta-D-galactosamine-specific lectin to Fc receptor-mediated phagocytosis by mouse peritoneal macrophages.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Jul; 79(3):403-7. PubMed ID: 8406569
[TBL] [Abstract][Full Text] [Related]
14. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
[TBL] [Abstract][Full Text] [Related]
15. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
Yamamoto N; Naraparaju VR
Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
[TBL] [Abstract][Full Text] [Related]
16. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
Yamamoto N; Naraparaju VR
Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
[TBL] [Abstract][Full Text] [Related]
17. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues.
Yamamoto N; St Claire DA; Homma S; Ngwenya BZ
Cancer Res; 1988 Nov; 48(21):6044-9. PubMed ID: 3167855
[TBL] [Abstract][Full Text] [Related]
18. Participation of serum proteins in the inflammation-primed activation of macrophages.
Yamamoto N; Willett NP; Lindsay DD
Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
[TBL] [Abstract][Full Text] [Related]
19. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
Ngwenya BZ; Yamamoto N
Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
[TBL] [Abstract][Full Text] [Related]
20. Activation of peritoneal macrophages by lysophosphatidylcholine.
Ngwenya BZ; Yamamoto N
Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
